These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 11016911

  • 1. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
    Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD.
    Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 3. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
    Ose L, Shah A, Davies MJ, Rotonda J, Maccubbin D, Tribble D, Veltri E, Mitchel Y.
    Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
    [Abstract] [Full Text] [Related]

  • 4. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 7. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 8. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P.
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [Abstract] [Full Text] [Related]

  • 9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 10. Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events.
    Michelena HI, Osorio LA, Citkowitz E.
    Int J Cardiol; 2005 May 11; 101(1):111-4. PubMed ID: 15860392
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D, Morgan C, Rigby RJ, Westhuyzen J.
    Am J Kidney Dis; 2002 Feb 11; 39(2):283-90. PubMed ID: 11840368
    [Abstract] [Full Text] [Related]

  • 12. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Feb 11; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 13. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 11; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 11; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 15. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct 11; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 16. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 11; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 17. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients.
    Dobs AS, Miller S, Neri G, Weiss S, Tate AC, Shapiro DR, Musliner TA.
    Metabolism; 2000 Jan 11; 49(1):115-21. PubMed ID: 10647074
    [Abstract] [Full Text] [Related]

  • 18. Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
    Insull W, Davidson MH, Kulkarni PM, Siddhanti S, Ciaccia AV, Keech CA.
    Metabolism; 2005 Jul 11; 54(7):939-46. PubMed ID: 15988705
    [Abstract] [Full Text] [Related]

  • 19. [The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels].
    Pirat B, Korkmaz ME, Eroğlu S, Tayfun E, Yildirir A, Uluçam M, Ozin B, Müderrisoğlu H.
    Anadolu Kardiyol Derg; 2004 Dec 11; 4(4):318-22. PubMed ID: 15590360
    [Abstract] [Full Text] [Related]

  • 20. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
    Brohet C, Banai S, Alings AM, Massaad R, Davies MJ, Allen C.
    Curr Med Res Opin; 2005 Apr 11; 21(4):571-8. PubMed ID: 15899106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.